Small intestinal fibrosarcoma

Summary

Small intestinal fibrosarcoma (MONDO:0004028) is a disease. A subtype of small intestinal sarcoma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	small intestinal fibrosarcoma
Mondo ID	MONDO:0004028
DOID	DOID:6880
NCIT	C5336
UMLS	C1335994
MedGen	234788
GARD	0023784
Anatomy (UBERON)	UBERON:0002108
Is cancer (heuristic)	no

Also known as: fibrosarcoma of small bowel · fibrosarcoma of small intestine · fibrosarcoma of the small bowel · fibrosarcoma of the small intestine · fibrosarcoma, small intestine · small bowel fibrosarcoma · small intestinal fibrosarcoma · small intestine fibrosarcoma · small intestine fibrosarcoma (disease)

Disease family

This is a subtype of small intestinal sarcoma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorder › intestinal disorder › intestinal neoplasm › small intestine neoplasm › small intestine cancer › small intestinal sarcoma › small intestinal fibrosarcoma

Related subtypes (1): small intestine leiomyosarcoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.